Curcumin induces tumor suppression in ameloblastoma by promoting apoptotic mechanism via MiR-9 expression: A narrative review
Downloads
Background: Ameloblastoma is a neoplastic odontogenic tumor that has a local invasive characteristic. The current treatment for ameloblastoma requires a precise surgical resection and chemotherapy. It requires a different approach to diminish the therapy drawbacks. Curcumin, as one of the most common well-described compounds, remarkably has a potential antitumor agent. Method: Our findings and opinions are based on a comprehensive search through scientific resources and correspondingly relating all the keywords using the Boolean technique and Medical Subject Headings (MeSH) term search to find the interest study. Review: By understanding curcumin and its target genes, curcumin itself can induce regulation of tumor suppression and oncogenic microRNA. MiR-9 has proven to be expressed for modulating the mutation genes causing tumorogenesis in ameloblastoma. Curcumin also upregulates miR-9, causing cytotoxic activity against cancers in many proven studies. Conclusion: The highly expressed miR-9 curcumin-mediated ameloblastoma inhibition will be the new insight and adjunct cancer therapy.
Yulvie W, Wijaya A, Handjari DR, Rahadiani N, Sulistyani LD, Tofani I. Demographic Variation of Ameloblastoma: A Retrospective Analysis of 188 Cases in the Indonesian Population. J Int Dent Med Res. 2023;16(1):209–13.
Widiastuti MG, Soesatyo MH, Magetsari R, Tontowi AE. Evaluasi Komplikasi Plate Exposure Pasca Reseksi Amelobl Astoma Mandibula Dengan Rekonstruksi Pelat Titanium Di RSUP Dr. Sardjito Yogyakarta. J Teknosains. 2017 Aug 30;5(2):81.
Rios Esposito N, Moreno Ferrer FA, Romo Sanhueza L. Conservative treatment of Ameloblastoma: report of 2 cases and review of the literature. ARS MEDICA Rev Ciencias Médicas. 2023 Aug 8;48(4):54–60.
Singh M, Shah A, Bhattacharya A, Raman R, Ranganatha N, Prakash P. Treatment Algorithm for Ameloblastoma. Case Rep Dent. 2014;1:121032.
Rocha AC, Fonseca FP, Santos-Silva AR, Lourenço SV, Ceccheti MM, Júnior JG. Effectiveness of the Conservative Surgical Management of the Ameloblastomas: A Cross-Sectional Study. Front Oral Heal. 2021 Oct 29;2:737424.
Sekarini AAAD, Krissanti I, Syamsunarno MRAA. Efektivitas Antibakteri Senyawa Kurkumin Terhadap Foodborne Bacteria: Tinjauan Curcuma longa Untuk Mengatasi Resistensi Antibiotik. J Sains Kesehat. 2020;2(4):538–47.
Dandriyal R, Lal V, Giri KY, Indra Bavanthabettu N, Chaurasia A, Pant S. Ameloblastoma: Retrospective Study and Analysis of 102 Cases Over 10 Years, Single Centre, Institutional Experience. J Maxillofac Oral Surg. 2022 Jun;21(2):730–8.
Santosa D, Suharti C, Riwanto I, Dharmana E, Pangarsa EA, Setiawan B, et al. Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial. Casp J Intern Med. 2022;13(2):375–84.
SUBOSITI D, WAHYONO S. Study of the genus Curcuma in Indonesia used as traditional herbal medicines. Biodiversitas J Biol Divers. 2019 Apr 25;20(5):1356–61.
Nurhayati IP, Maysaroh I, Ihsan B. Validasi Metode Ultra High Peformance Chromatography Double Mass Spectrophotometry (UHPLC-MS/MS) untuk Analisis Kurkumin pada Ekstrak Etanol Kunyit (Curcuma longa) dengan Berbagai Perbandingan Konsentrasi. Pharm J Indones. 2018;4(1):29–34.
Setién-Olarra A, Marichalar-Mendia X, Bediaga NG, Aguirre-Echebarria P, Aguirre-Urizar JM, Mosqueda-Taylor A. MicroRNAs expression profile in solid and unicystic ameloblastomas. PLoS One. 2017;12(10):e0186841.
Guo L-M, Pu Y, Han Z, Liu T, Li Y-X, Liu M, et al. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J. 2009 Oct;276(19):5537–46.
Jia C-Y, Xiang W, Liu J-B, Jiang G-X, Sun F, Wu J-J, et al. MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer. Technol Cancer Res Treat. 2021 Jan 14;20:15330338211041192.
Shi C, Cao J, Shi T, Liang M, Ding C, Lv Y, et al. BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features. World J Surg Oncol. 2020 Dec 27;18(1):145.
Paknia F, Parchami N, Nasry N, Mohabatkar H. Therapeutic activities and biological effects of curcumin, as a natural multi-target compound, on human health: A minireview. J Shahrekord Univ Med Sci. 2022 Aug 18;24(3):145–52.
Salehinejad J, Zare-Mahmoodabadi R, Saghafi S, Jafarian A-H, Ghazi N, Rajaei A-R, et al. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor. J Oral Sci. 2011 Jun;53(2):213–7.
de A, Andrade D, Schlaepfer S, Carneiro B, Martins MT, Freitas V, et al. STAT3 gene expression in ameloblastomas and odontogenic keratocysts. Srp Arh Celok Lek. 2023;151(1–2):15–20.
Iriti M, Varoni E. Chemopreventive Potential of Flavonoids in Oral Squamous Cell Carcinoma in Human Studies. Nutrients. 2013 Jul 8;5(7):2564–76.
Butnariu M, Quispe C, Sharifi-Rad J, Pons-Fuster E, Lopez-Jornet P, Zam W, et al. Naturally-Occurring Bioactives in Oral Cancer: Preclinical and Clinical Studies, Bottlenecks and Future Directions. Front Biosci (Schol Ed). 2022 Aug 19;14(3):24.
Harsha C, Banik K, Ang HL, Girisa S, Vikkurthi R, Parama D, et al. Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials. Int J Mol Sci. 2020 May 6;21(9):3285.
Tang W, Du M, Zhang S, Jiang H. Therapeutic effect of curcumin on oral diseases: A literature review. Phytother Res. 2021 May;35(5):2287–95.
Zhen L, Fan D, Yi X, Cao X, Chen D, Wang L. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways. Int J Clin Exp Pathol. 2014;7(10):6438–46.
Shin HK, Kim J, Lee EJ, Kim SH. Inhibitory effect of curcumin on motility of human oral squamous carcinoma YD-10B cells via suppression of ERK and NF-kappaB activations. Phytother Res. 2010 Apr;24(4):577–82.
Yang Z, Li K, Liang Q, Zheng G, Zhang S, Lao X, et al. Elevated hydrostatic pressure promotes ameloblastoma cell invasion through upregulation of MMP-2 and MMP-9 expression via Wnt/β-catenin signalling. J Oral Pathol Med. 2018 Oct;47(9):836–46.
Nigam K, Srivastav RK. Notch signaling in oral pre-cancer and oral cancer. Med Oncol. 2021 Oct 11;38(12):139.
Shehzad A, Lee YS. Molecular mechanisms of curcumin action: signal transduction. Biofactors. 2013;39(1):27–36.
Ruiz de Porras V, Layos L, Martínez-Balibrea E. Curcumin: A therapeutic strategy for colorectal cancer? Semin Cancer Biol. 2021 Aug;73:321–30.
Shi HA, Ng CWB, Kwa CT, Sim QXC. Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies. Surg. 2021 Aug;19(4):238–43.
Yoithapprabhunath TR, Srichinthu KK, Gupta D, Singh D, Pasupuleti S, Nirmal RM. Effectiveness of Molecular-Targeted Chemotherapy in Ameloblastomas. Indian J Dent Res. 2022 Jul;33(3):323–31.
Larrañaga JJ, Sahovaler A, Picco P, Mazzaro E, Figari M. Management Issues in the Treatment of an Ameloblastoma with an Atypical Presentation. Craniomaxillofac Trauma Reconstr. 2015 Sep 1;8(3):257–61.
Kurppa KJ, Catón J, Morgan PR, Ristimäki A, Ruhin B, Kellokoski J, et al. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol [Internet]. 2014 Apr;232(5):492–8. Available from: https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.4317
Chae MP, Smoll NR, Hunter-Smith DJ, Rozen WM. Establishing the Natural History and Growth Rate of Ameloblastoma with Implications for Management: Systematic Review and Meta-Analysis. Elsalanty M, editor. PLoS One. 2015 Feb 23;10(2):e0117241.
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019 Apr 15;144(8):1941–53.
Chow H-HS, Hakim IA. Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res. 2011 May;64(2):105–12.
Yoon A, Shen J, Santella R, Philipone E, Wu H-C, Eisig S, et al. Topical application of green tea polyphenol (−) epigallocatechin-3-gallate for prevention of recurrent oral neoplastic lesions. J Orofac Sci. 2012;4(1):43.
Li F, Shanmugam MK, Chen L, Chatterjee S, Basha J, Kumar AP, et al. Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma. Cancer Prev Res (Phila). 2013 Aug;6(8):843–54.
Wolf MA, Claudio PP. Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin. Nutr Cancer. 2014;66(2):285–94.
Bhavana SM, Lakshmi CR. Oral oncoprevention by phytochemicals - a systematic review disclosing the therapeutic dilemma. Adv Pharm Bull. 2014 Oct;4(Suppl 1):413–20.
Ghasemi F, Shafiee M, Banikazemi Z, Pourhanifeh MH, Khanbabaei H, Shamshirian A, et al. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. Pathol Res Pract. 2019 Oct;215(10):152556.
Xiao X, Yang G, Bai P, Gui S, Nyuyen TMB, Mercado-Uribe I, et al. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway. BMC Cancer. 2016 Aug 2;16:582.
Yang S, Sun Y, Kapilevich L, Zhang X, Huang Y. Protective effects of curcumin against osteoporosis and its molecular mechanisms: a recent review in preclinical trials. Front Pharmacol. 2023 Sep 18;14:1249418.
Yang C, Zhu K, Yuan X, Zhang X, Qian Y, Cheng T. Curcumin has immunomodulatory effects on RANKL-stimulated osteoclastogenesis in vitro and titanium nanoparticle-induced bone loss in vivo. J Cell Mol Med. 2020 Jan;24(2):1553–67.
Oh S, Kyung T-W, Choi H-S. Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells. Mol Cells. 2008 Nov 30;26(5):486–9.
Ke D, Wang Y, Yu Y, Wang Y, Zheng W, Fu X, et al. Curcumin-activated autophagy plays a negative role in its anti-osteoclastogenic effect. Mol Cell Endocrinol. 2020 Jan;500:110637.
Heo DN, Ko W-K, Moon H-J, Kim H-J, Lee SJ, Lee JB, et al. Inhibition of osteoclast differentiation by gold nanoparticles functionalized with cyclodextrin curcumin complexes. ACS Nano. 2014 Dec 23;8(12):12049–62.
Kim WK, Ke K, Sul OJ, Kim HJ, Kim SH, Lee MH, et al. Curcumin protects against ovariectomy-induced bone loss and decreases osteoclastogenesis. J Cell Biochem. 2011 Nov;112(11):3159–66.
Ethiraj P, Sambandam Y, Hathaway-Schrader JD, Haque A, Novince CM, Reddy S V. RANKL triggers resistance to TRAIL-induced cell death in oral squamous cell carcinoma. J Cell Physiol. 2020 Feb;235(2):1663–73.
Atabaki M, Shariati-Sarabi Z, Tavakkol-Afshari J, Taghipour A, Jafari MR, Nikpoor AR, et al. Curcumin as an effective suppressor of miRNA expression in patients with knee osteoarthritis. Avicenna J phytomedicine. 2022;12(4):346–56.
Saini S, Arora S, Majid S, Shahryari V, Chen Y, Deng G, et al. Curcumin Modulates MicroRNA-203–Mediated Regulation of the Src-Akt Axis in Bladder Cancer. Cancer Prev Res. 2011 Oct 1;4(10):1698–709.
Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A. Curcumin as a MicroRNA Regulator in Cancer: A Review. Rev Physiol Biochem Pharmacol. 2016;171:1–38.
Lu Y, Zhang X, Li X. Molecular biology exploration and targeted therapy strategy of Ameloblastoma. Arch Oral Biol. 2022 Aug;140:105454.
Hu Q, Huang T. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition. Int J Mol Sci. 2023 May 18;24(10):8939.
Mirzaei H, Masoudifar A, Sahebkar A, Zare N, Sadri Nahand J, Rashidi B, et al. MicroRNA: A novel target of curcumin in cancer therapy. J Cell Physiol. 2018 Apr;233(4):3004–15.
Zhao S-F, Zhang X, Zhang X-J, Shi X-Q, Yu Z-J, Kan Q-C. Induction of microRNA-9 mediates cytotoxicity of curcumin against SKOV3 ovarian cancer cells. Asian Pac J Cancer Prev. 2014;15(8):3363–8.
Liu Y, Shen Z, Zhu T, Lu W, Fu Y. Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis. Front Pharmacol. 2022;13:1014933.
Xiao C, Wang L, Zhu L, Zhang C, Zhou J. Curcumin inhibits oral squamous cell carcinoma SCC-9 cells proliferation by regulating miR-9 expression. Biochem Biophys Res Commun. 2014 Nov 28;454(4):576–80.
Markopoulos G, Roupakia E, Tokamani M, Alabasi G, Sandaltzopoulos R, Marcu K, et al. Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer. Biomedicines. 2018 Mar 30;6(2):40.
Copyright (c) 2024 Hilmy Irsyadi Hanif, Reisca Tiara Hardiyani, Intan Dzahabiyah Septiani, Heni Susilowati
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Lisence, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Copyright notice:
IJDM by UNAIR is licensed under a Creative Commons Atribusi 4.0 Internasional.
- The journal allows the author to hold the copyright of the article without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution (CC BY)
